Rolex Pharmaceuticals Limited - Company Profile

It is a chemicals public limited company based in Vadodara, Gujarat, India, established in 1986.
1986 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Rolex Pharmaceuticals Limited

Rolex Pharmaceuticals Limited, a active public limited company, was established on 03 July 1986 in Vadodara, Gujarat, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232GJ1986PLC008767. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.93 Cr.

It upholds a compliant status. Its leadership includes Amit Dilipkumar Joshi (Director), Ragini Dilipkumar Joshi (Director), Dilipbhai Hariprasad Joshi (Managing Director). Past directors included Nilam Sanatkumar Trivedi, Amit Dilipkumar Joshi, Sujal Manishbhai Patel. It holds no open charges and ₹1.54 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 4Th Floor,Mruduna Sadan Pratap Road, Vadodara, Gujarat, 390001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ1986PLC008767

  • Registration Number

    008767

  • Incorporation Date

    03 July 1986

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.93 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.93 Cr
  • Company Age 39 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 1.54 Cr
  • Revenue Growth **** -65.39%
  • Profit Growth **** -5.14%
  • Ebitda **** -44.99%
  • Net Worth 0.02%
  • Total Assets -1.23%
Company report

Rolex Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rolex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rolex Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Amit Dilipkumar Joshi Director 01 Jun 2010 Current
Ragini Dilipkumar Joshi Director 06 Jan 1992 Current
Dilipbhai Hariprasad Joshi Managing Director 03 Jul 1986 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Mar 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Additional Director 20 Nov 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rolex Pharmaceuticals.

Rolex Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 65.39% decrease. The company also saw a slight decrease in profitability, with a 5.14% decrease in profit. The company's net worth moved up by a moderate rise of 0.02%.

Rolex Pharmaceuticals revenue growth over time
Rolex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -65.39%
*******
*******
*******
*******
Revenue from Operations
*******
 -65.39%
*******
*******
*******
*******
Total Assets
*******
 -1.23%
*******
*******
*******
*******
Profit or Loss
*******
 -5.14%
*******
*******
*******
*******
Net Worth
*******
 0.02%
*******
*******
*******
*******
EBITDA
*******
 -44.99%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rolex Pharmaceuticals?

In 2017, Rolex Pharmaceuticals had a promoter holding of 25.13% and a public holding of 74.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹15,449,000.00

Charges Breakdown by Lending Institutions
  • Industrial Development Bank Of India : 1.30 Cr
  • Gujarat State Financial Corporation : 0.14 Cr
  • Bank Of Baroda : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
31 Jan 1994 Industrial Development Bank Of India ₹1.30 Cr Satisfied
08 Jul 1993 Bank Of Baroda ₹1.00 M Satisfied
27 Mar 1989 Gujarat State Financial Corporation ₹1.45 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rolex Pharmaceuticals?

Unlock and access historical data on people associated with Rolex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rolex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rolex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rolex Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rolex Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Rolex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    A charge registered on 08 Jul 1993 via Charge ID 90315120 with Bank Of Baroda was fully satisfied on 07 Jun 2017. was recorded as a recent event.

  • Charges

    The activity A charge registered on 31 Jan 1994 via Charge ID 90315204 with Industrial Development Bank Of India was fully satisfied on 14 Jul 2010. was completed.

  • Charges

    A charge registered on 27 Mar 1989 via Charge ID 90314310 with Gujarat State Financial Corporation was fully satisfied on 02 Jul 2010. was recorded as a recent event.

  • Director Appointment

    Amit Dilipkumar Joshi was appointed as a Director was appointed as a Director on 01 Jun 2010 & has been associated with this company since 15 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rolex Pharmaceuticals Limited?

The CIN of Rolex Pharmaceuticals Limited is U24232GJ1986PLC008767.

Where is Rolex Pharmaceuticals Limited headquartered?

Rolex Pharmaceuticals Limited is headquartered at 4Th Floor,Mruduna Sadan Pratap Road, Vadodara, Gujarat, 390001.

When was Rolex Pharmaceuticals Limited incorporated?

Rolex Pharmaceuticals Limited was incorporated on 03 July 1986.

Who are the current directors of Rolex Pharmaceuticals Limited?

The current directors of Rolex Pharmaceuticals Limited are

What is the primary industry of Rolex Pharmaceuticals Limited?

The primary industry of Rolex Pharmaceuticals Limited is Chemicals.

Is Rolex Pharmaceuticals Limited a listed company?

Rolex Pharmaceuticals Limited is unlisted.

What is the capital structure of Rolex Pharmaceuticals Limited?

The authorized capital of Rolex Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.93 Cr.

What is the compliance status of Rolex Pharmaceuticals Limited?

The compliance status of Rolex Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available